Banka BioLoo Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.'.
BANKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Banka BioLoo's subsidiary, Megaliter Varunaa Private Limited, is raising fresh capital from external investors to fund growth in wastewater treatment operating assets. The external investors are Old Bridge Capital Management Private Limited, Micro Strategies Fund (a SEBI-registered Category III AIF), and Massachusetts Institute of Technology (a SEBI-registered FPI). As part of this, the company's stake in Megaliter will dilute from 92.50% to 70% over the fund-raising period. Banka BioLoo will remain the largest shareholder with no change in control of the subsidiary. The external investors will get the right to appoint a director to Megaliter's board, and all parties will have pre-emptive rights on future share issuances. The funding will come in tranches, and a Restated and Amended Shareholders' Agreement is being signed. This is a subsidiary-level event and does not directly impact the listed company's equity base.
For Banka BioLoo shareholders, this means a meaningful economic dilution at the subsidiary level (from 92.5% to 70%), but the listed company retains control. Attracting marquee investors like MIT and Old Bridge Capital is a positive validation of the wastewater treatment business, though near-term value of subsidiary earnings to consolidated shareholders will be lower. The stock may see limited direct impact since the raise is at the unlisted subsidiary level.